Online citations, reference lists, and bibliographies.
← Back to Search

Codelivery Of Doxorubicin And Triptolide With Reduction-sensitive Lipid–polymer Hybrid Nanoparticles For In Vitro And In Vivo Synergistic Cancer Treatment

B. Wu, Shuting Lu, Liu-jie Zhang, R. Zhuo, H. Xu, Shiwen Huang
Published 2017 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Codelivery is a promising strategy to overcome the limitations of single chemotherapeutic agents in cancer treatment. Despite progress, codelivery of two or more different functional drugs to increase anticancer efficiency still remains a challenge. Here, reduction-sensitive lipid–polymer hybrid nanoparticles (LPNPs) drug delivery system composed of monomethoxy-poly(ethylene glycol)-S-S-hexadecyl (mPEG-S-S-C16), soybean lecithin, and poly(D,L-lactide-co-glycolide) (PLGA) was used for codelivery of doxorubicin (DOX) and a Chinese herb extract triptolide (TPL). Hydrophobic DOX and TPL could be successfully loaded in LPNPs by self-assembly. More importantly, drug release and cellular uptake experiments demonstrated that the two drugs were reduction sensitive, released simultaneously from LPNPs, and taken up effectively by the tumor cells. DOX/TPL-coloaded LPNPs (DOX/TPL-LPNPs) exhibited a high level of synergistic activation with low combination index (CI) in vitro and in vivo. Moreover, the highest synergistic therapeutic effect was achieved at the ratio of 1:0.2 DOX/TPL. Further experiments showed that TPL enhanced the uptake of DOX by human oral cavity squamous cell carcinoma cells (KB cells). Overall, DOX/TPL-coencapsulated reduction-sensitive nanoparticles will be a promising strategy for cancer treatment.
This paper references
10.1016/j.oraloncology.2008.10.007
Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo.
Y. Chen (2009)
10.1021/nn400334y
Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy.
Mingbin Zheng (2013)
10.1039/C5MD00365B
Multi-drug delivery nanocarriers for combination therapy
Suresh Gadde (2015)
10.1016/J.JCONREL.2013.08.043
Polymer–lipid hybrid nanoparticles with reduction-triggered release for improved antitumor efficiency
C. Cui (2013)
10.1007/s11051-015-3217-9
Novel CD44 receptor targeting multifunctional “nano-eggs” based on double pH-sensitive nanoparticles for co-delivery of curcumin and paclitaxel to cancer cells and cancer stem cells
D. Chen (2015)
10.3892/ijo.2014.2280
Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
T. Nakazato (2014)
10.1142/S0192415X14500323
Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
K. Sai (2014)
10.1016/J.NANO.2015.12.195
Indocyanine green loaded lipid-polymer nanoparticles for cancer imaging and therapy
Mingbin Zheng (2016)
10.1016/j.biomaterials.2014.10.044
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.
Liqiong Cai (2015)
10.1038/nbt0909-864c
Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity
J. Lehar (2009)
10.3892/ijo.2015.2814
Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways
G. Meng (2015)
10.1021/nn800275r
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
L. Zhang (2008)
10.1039/c4bm00462k
Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.
B. Wu (2015)
10.1016/j.biomaterials.2008.12.013
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
J. M. Chan (2009)
10.1039/C3RA22417A
Bioactive constituents from toxic seed plants in China
Jing Qu (2013)
10.1016/j.biomaterials.2013.01.101
Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
C. Cui (2013)
10.1016/j.nano.2016.01.017
iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy.
J. Zhang (2016)
10.1038/leu.2017.77
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
W. Fiskus (2017)
10.1016/j.biomaterials.2014.04.019
Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles.
P. Zhao (2014)
10.1039/C5RA04032A
Synthesis, characterization and bifunctional applications of bidentate silver nanoparticle assisted single drop microextraction as a highly sensitive preconcentrating probe for protein analysis
L. Shastri (2015)
10.1021/JA00775A078
Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii.
S. M. Kupchan (1972)
10.1166/JNN.2015.9604
Lipid-Polymer Nanoparticles for Folate-Receptor Targeting Delivery of Doxorubicin.
Mingbin Zheng (2015)
10.1371/journal.pone.0107154
Synergistic Combination of Gemcitabine and Dietary Molecule Induces Apoptosis in Pancreatic Cancer Cells and Down Regulates PKM2 Expression
Archana Pandita (2014)
10.1039/C3RA47370H
Polymeric micelles as drug delivery vehicles
Z. Ahmad (2014)
10.1158/1538-7445.PANCA2014-B119
Abstract B119: Triptolide abrogates expression of the Met and epidermal growth factor receptors in pancreatic cancer
V. Sangwan (2015)
10.1016/j.biomaterials.2014.03.017
Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
Z. Yang (2014)
10.1016/J.CANLET.2005.10.001
Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
Chi-Keung Wan (2006)
10.3858/emm.2012.44.11.072
Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin
H. Zhao (2012)
10.1039/c2np00088a
Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.
Zhao-Li Zhou (2012)
10.1073/pnas.1115945108
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles
J. M. Chan (2011)
10.1002/smll.200900621
Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.
A. M. Chen (2009)
10.1039/c6bm00662k
Two-component reduction-sensitive lipid-polymer hybrid nanoparticles for triggered drug release and enhanced in vitro and in vivo anti-tumor efficacy.
Liu-jie Zhang (2016)
10.1016/j.ijpharm.2013.06.017
Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.
Hoang Hanh Phuoc Duong (2013)
10.1136/pgmj.2006.055426
Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma
X. Tang (2007)
10.1016/j.canlet.2012.01.006
Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.
C. Li (2012)
10.1039/c3cc49003c
Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells.
Fujian Huang (2014)
10.1007/S00396-009-2131-Z
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
M. J. Santander-Ortega (2010)
Lipid-coated polymeric nanoparticles for cancer drug delivery
G. Borges (2018)
10.1016/j.biomaterials.2010.07.082
PLGA/polymeric liposome for targeted drug and gene co-delivery.
H. Wang (2010)
10.1016/j.biomaterials.2014.04.034
Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
Shixian Lv (2014)
10.1016/j.biomaterials.2014.03.072
Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
T. Yin (2014)
10.1038/onc.2008.89
Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3β with p53
Y. Matsui (2008)
10.1039/C6RA07802H
Recent trends in nano-based drug delivery systems for efficient delivery of phytochemicals in chemotherapy
A. P. Subramanian (2016)



This paper is referenced by
10.2147/IJN.S143048
MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles
B. Wu (2017)
10.1016/j.msec.2018.03.031
Cisplatin and Ce6 loaded polyaniline nanoparticles: An efficient near-infrared light mediated synergistic therapeutic agent.
Chaoqun You (2019)
10.1016/B978-0-12-820658-4.00013-3
Inhalable hybrid nanocarriers for respiratory disorders
P. Maurya (2020)
The effects of TPL-PEI-CyD on suppressing performance of MCF-7 stem cells.
Y. Zhu (2020)
10.1016/j.ijpharm.2020.119882
Redox-sensitive nanoscale drug delivery systems for cancer treatment.
Elaheh Mirhadi (2020)
10.1016/j.biopha.2018.05.088
Broad targeting of triptolide to resistance and sensitization for cancer therapy.
Zhen-yan Hou (2018)
10.3389/fphar.2018.00104
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
Shaoru Chen (2018)
10.1080/17425247.2020.1739647
Co-delivery system of chemotherapy drugs and active ingredients from natural plants: a brief overview of preclinical research for cancer treatment
Pu Guo (2020)
10.1016/j.jconrel.2019.12.025
Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice.
P. Li (2019)
10.2147/IJN.S214377
Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy
D. Wang (2019)
10.3390/molecules24061035
Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs’ Dosage Ratio Effect
Jiayi Pan (2019)
10.1016/j.tips.2019.03.002
Triptolide and Its Derivatives as Cancer Therapies.
Pawan Noel (2019)
10.1016/j.jconrel.2019.03.015
Threatening cancer with nanoparticle aided combination oncotherapy
Shruti Rawal (2019)
10.1016/j.nano.2020.102338
A novel liposome-polymer hybrid nanoparticles delivering a multi-epitope self-replication DNA vaccine and its preliminary immune evaluation in experimental animals☆☆☆
Zhangting Zhao (2020)
10.1016/j.lfs.2018.03.023
Toxicity of Doxorubicin (Dox) to different experimental organ systems
A. Pugazhendhi (2018)
10.1016/j.xphs.2020.08.014
Perspectives About Self-Immolative Drug Delivery Systems.
Rodrigo Vieira Gonzaga (2020)
10.1089/ars.2017.7412
Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
Shamim Akhtar Sufi (2019)
10.1080/21691401.2017.1376675
Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment
M. Afsharzadeh (2018)
10.1016/j.biopha.2019.109006
Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
G. Zheng (2019)
10.1016/j.ejpb.2018.04.001
Effective delivery of hydrophobic drugs to breast and liver cancer cells using a hybrid inorganic nanocarrier: A detailed investigation using cytotoxicity assays, fluorescence imaging and flow cytometry
D. C. Manatunga (2018)
10.2147/DDDT.S172199
Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
J. Liu (2018)
10.1248/bpb.b18-00818
Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
W. Jiang (2019)
10.3390/pharmaceutics10030074
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs
X. Zhang (2018)
10.1007/s13346-020-00827-z
Therapeutic applications and delivery systems for triptolide
J. Viegas (2020)
10.2147/DDDT.S178569
Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment
D. Xu (2018)
Effective delivery of hydrophobic drugs to breast (MCF-7) and Liver (HepG2) cancer cells: A detailed investigation using Cytotoxicity assays, fluorescence imaging and flow cytometry
D. C. Manatunga (2018)
10.2147/IJN.S182197
pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy
C. Xu (2018)
10.1007/s11655-020-3191-7
Huayu Pill (化瘀丸) Promotes Fluorescent Doxorubicin Delivery to Tumors in Mouse Model of Lung Cancer
Lei Gao (2020)
10.1016/j.jconrel.2019.10.005
Zebrafish, a model to develop nanotherapeutics that control neutrophils response during inflammation.
J. P. García-López (2019)
10.1016/j.plipres.2017.07.001
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
M. C. Teixeira (2017)
Semantic Scholar Logo Some data provided by SemanticScholar